Lv31
398 积分 2023-04-04 加入
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
6小时前
已完结
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial
7小时前
已完结
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
7小时前
已完结
Estimating an EQ-5D-5L Value Set for China
3天前
已完结
[Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China]
13天前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
1个月前
已完结
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
1个月前
已完结
Optimizing bone health with bisphosphonate therapies in pediatric osteogenesis imperfecta: a network meta-analysis of randomized trials
1个月前
已完结
Efficacy of CO2 laser treatment in postmenopausal women with vulvovaginal atrophy: A meta‐analysis
2个月前
已完结
皖公网安备34019202002308
